Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Inflammatory Bowel Diseases | 85 | 2024 | 2442 | 12.510 |
Why?
|
Crohn Disease | 76 | 2024 | 2293 | 9.380 |
Why?
|
Drug Monitoring | 36 | 2024 | 964 | 8.800 |
Why?
|
Gastrointestinal Agents | 38 | 2024 | 510 | 7.660 |
Why?
|
Colitis, Ulcerative | 51 | 2024 | 1929 | 5.300 |
Why?
|
Tumor Necrosis Factor-alpha | 36 | 2023 | 4357 | 4.260 |
Why?
|
Biological Products | 14 | 2024 | 934 | 2.980 |
Why?
|
Azathioprine | 8 | 2022 | 354 | 2.430 |
Why?
|
Colonoscopy | 14 | 2020 | 1412 | 2.060 |
Why?
|
Antibodies, Monoclonal | 30 | 2024 | 9261 | 1.950 |
Why?
|
Colitis | 9 | 2022 | 1244 | 1.750 |
Why?
|
Immunosuppressive Agents | 15 | 2022 | 4209 | 1.680 |
Why?
|
Remission Induction | 18 | 2024 | 2407 | 1.660 |
Why?
|
Practice Guidelines as Topic | 14 | 2021 | 7453 | 1.530 |
Why?
|
Immunologic Factors | 13 | 2024 | 1598 | 1.480 |
Why?
|
Capsule Endoscopy | 6 | 2021 | 106 | 1.270 |
Why?
|
Anti-Inflammatory Agents | 8 | 2024 | 1812 | 1.080 |
Why?
|
Mesalamine | 9 | 2016 | 134 | 1.050 |
Why?
|
Gastroenterology | 5 | 2021 | 589 | 1.030 |
Why?
|
Guideline Adherence | 5 | 2020 | 2240 | 1.000 |
Why?
|
Conflict of Interest | 6 | 2016 | 555 | 1.000 |
Why?
|
Serum | 3 | 2017 | 207 | 0.980 |
Why?
|
Evidence-Based Medicine | 7 | 2016 | 3707 | 0.950 |
Why?
|
Endoscopy, Gastrointestinal | 5 | 2023 | 887 | 0.890 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 14 | 2016 | 2277 | 0.860 |
Why?
|
Medical Records | 4 | 2017 | 1413 | 0.850 |
Why?
|
Bronchial Diseases | 2 | 2014 | 151 | 0.840 |
Why?
|
Humans | 197 | 2024 | 768298 | 0.810 |
Why?
|
Standard of Care | 4 | 2022 | 570 | 0.800 |
Why?
|
Rectal Fistula | 2 | 2024 | 76 | 0.780 |
Why?
|
Sickness Impact Profile | 2 | 2013 | 299 | 0.780 |
Why?
|
Pulmonary Medicine | 2 | 2014 | 223 | 0.770 |
Why?
|
Documentation | 3 | 2017 | 917 | 0.750 |
Why?
|
Colectomy | 3 | 2015 | 695 | 0.730 |
Why?
|
Intestinal Fistula | 1 | 2021 | 144 | 0.700 |
Why?
|
Nephrology | 2 | 2014 | 270 | 0.690 |
Why?
|
Intestinal Neoplasms | 2 | 2020 | 316 | 0.680 |
Why?
|
Calculi | 1 | 2019 | 48 | 0.640 |
Why?
|
Fertilization in Vitro | 3 | 2016 | 1302 | 0.640 |
Why?
|
Triage | 2 | 2015 | 994 | 0.600 |
Why?
|
Hepatitis B Core Antigens | 1 | 2018 | 90 | 0.600 |
Why?
|
Hepatitis B Antibodies | 1 | 2018 | 155 | 0.570 |
Why?
|
Irritable Bowel Syndrome | 2 | 2013 | 454 | 0.570 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2018 | 294 | 0.550 |
Why?
|
Diarrhea | 3 | 2017 | 1320 | 0.540 |
Why?
|
Drug Tolerance | 2 | 2018 | 366 | 0.540 |
Why?
|
Coloring Agents | 1 | 2019 | 563 | 0.540 |
Why?
|
Hepatitis B virus | 2 | 2018 | 527 | 0.540 |
Why?
|
Colonic Neoplasms | 5 | 2020 | 2542 | 0.530 |
Why?
|
Light | 2 | 2020 | 1354 | 0.530 |
Why?
|
Adult | 74 | 2024 | 223622 | 0.530 |
Why?
|
Arthritis, Psoriatic | 1 | 2019 | 217 | 0.530 |
Why?
|
Immunocompromised Host | 2 | 2012 | 863 | 0.520 |
Why?
|
Virus Activation | 1 | 2018 | 322 | 0.520 |
Why?
|
Helicobacter pylori | 1 | 2019 | 381 | 0.510 |
Why?
|
Helicobacter Infections | 1 | 2019 | 391 | 0.510 |
Why?
|
Cannabis | 1 | 2021 | 445 | 0.490 |
Why?
|
Middle Aged | 65 | 2024 | 223463 | 0.480 |
Why?
|
Disease Management | 6 | 2021 | 2536 | 0.480 |
Why?
|
Male | 87 | 2024 | 364870 | 0.470 |
Why?
|
Apyrase | 5 | 2020 | 376 | 0.470 |
Why?
|
C-Reactive Protein | 8 | 2024 | 3859 | 0.470 |
Why?
|
Obstetric Labor Complications | 1 | 2017 | 243 | 0.470 |
Why?
|
Complementary Therapies | 2 | 2016 | 487 | 0.460 |
Why?
|
Infertility | 3 | 2016 | 655 | 0.460 |
Why?
|
Female | 89 | 2024 | 397050 | 0.450 |
Why?
|
Therapeutic Irrigation | 2 | 2014 | 297 | 0.440 |
Why?
|
Herpesvirus 3, Human | 2 | 2012 | 159 | 0.440 |
Why?
|
Intestine, Small | 4 | 2013 | 1218 | 0.430 |
Why?
|
Pouchitis | 3 | 2022 | 64 | 0.420 |
Why?
|
Emergency Service, Hospital | 4 | 2018 | 7955 | 0.420 |
Why?
|
Treatment Outcome | 30 | 2024 | 65365 | 0.410 |
Why?
|
Intestinal Obstruction | 2 | 2006 | 434 | 0.410 |
Why?
|
Mycobacterium marinum | 1 | 2012 | 29 | 0.410 |
Why?
|
Barrett Esophagus | 1 | 2016 | 494 | 0.400 |
Why?
|
Coronary Angiography | 2 | 2014 | 4537 | 0.390 |
Why?
|
Antirheumatic Agents | 2 | 2012 | 1378 | 0.390 |
Why?
|
Herpes Zoster | 2 | 2012 | 252 | 0.390 |
Why?
|
Treatment Failure | 5 | 2019 | 2664 | 0.390 |
Why?
|
Skin Diseases, Bacterial | 1 | 2012 | 65 | 0.390 |
Why?
|
Chickenpox | 1 | 2012 | 96 | 0.380 |
Why?
|
Drug Evaluation | 1 | 2012 | 642 | 0.380 |
Why?
|
Mycophenolic Acid | 1 | 2013 | 350 | 0.370 |
Why?
|
Cannabinoids | 1 | 2013 | 175 | 0.370 |
Why?
|
Cryptosporidium | 1 | 2011 | 43 | 0.370 |
Why?
|
Cryptosporidiosis | 1 | 2011 | 52 | 0.370 |
Why?
|
Cyclosporine | 2 | 2011 | 779 | 0.370 |
Why?
|
Comparative Effectiveness Research | 3 | 2020 | 712 | 0.370 |
Why?
|
Th17 Cells | 5 | 2022 | 791 | 0.370 |
Why?
|
Pharmaceutical Preparations | 1 | 2019 | 1088 | 0.370 |
Why?
|
Drug Hypersensitivity | 2 | 2014 | 923 | 0.360 |
Why?
|
Capsule Endoscopes | 2 | 2009 | 13 | 0.360 |
Why?
|
Arthritis, Rheumatoid | 2 | 2019 | 3776 | 0.360 |
Why?
|
Medication Adherence | 5 | 2015 | 2189 | 0.350 |
Why?
|
Adrenal Cortex Hormones | 4 | 2014 | 1890 | 0.340 |
Why?
|
Infertility, Female | 1 | 2016 | 765 | 0.340 |
Why?
|
Delivery, Obstetric | 1 | 2017 | 952 | 0.340 |
Why?
|
Tomography, X-Ray Computed | 5 | 2016 | 20766 | 0.340 |
Why?
|
Iatrogenic Disease | 1 | 2013 | 552 | 0.340 |
Why?
|
Osteoporosis | 1 | 2019 | 1606 | 0.330 |
Why?
|
Retrospective Studies | 26 | 2024 | 81768 | 0.330 |
Why?
|
Vaccines, Attenuated | 1 | 2011 | 314 | 0.330 |
Why?
|
Opportunistic Infections | 1 | 2012 | 375 | 0.330 |
Why?
|
Cellulitis | 1 | 2011 | 206 | 0.330 |
Why?
|
Colonic Polyps | 1 | 2014 | 557 | 0.330 |
Why?
|
Immunomodulation | 1 | 2013 | 549 | 0.320 |
Why?
|
Health Priorities | 1 | 2012 | 380 | 0.320 |
Why?
|
Attitude of Health Personnel | 3 | 2021 | 3921 | 0.310 |
Why?
|
Drug Substitution | 2 | 2021 | 291 | 0.310 |
Why?
|
Tumor Necrosis Factors | 2 | 2019 | 109 | 0.310 |
Why?
|
Research Support as Topic | 1 | 2012 | 696 | 0.300 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2020 | 4047 | 0.300 |
Why?
|
Young Adult | 27 | 2024 | 60048 | 0.300 |
Why?
|
Cesarean Section | 1 | 2017 | 1417 | 0.300 |
Why?
|
Potentilla | 1 | 2007 | 1 | 0.300 |
Why?
|
Infusions, Parenteral | 1 | 2008 | 397 | 0.300 |
Why?
|
Patient Care | 1 | 2013 | 629 | 0.300 |
Why?
|
Congenital Abnormalities | 1 | 2013 | 708 | 0.290 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2020 | 10776 | 0.280 |
Why?
|
Cytomegalovirus Infections | 1 | 2013 | 839 | 0.270 |
Why?
|
Endoscopes, Gastrointestinal | 1 | 2006 | 45 | 0.270 |
Why?
|
Adenoma | 2 | 2014 | 2163 | 0.270 |
Why?
|
Lichen Planus, Oral | 1 | 2007 | 57 | 0.270 |
Why?
|
Colon | 5 | 2017 | 1805 | 0.270 |
Why?
|
Colorectal Neoplasms | 3 | 2014 | 6969 | 0.260 |
Why?
|
Hepatitis B | 1 | 2011 | 707 | 0.260 |
Why?
|
Private Practice | 2 | 2017 | 155 | 0.260 |
Why?
|
Antigens, CD | 4 | 2020 | 4031 | 0.250 |
Why?
|
Education, Medical | 1 | 2017 | 1742 | 0.250 |
Why?
|
Clinical Protocols | 3 | 2009 | 1445 | 0.250 |
Why?
|
Skin Diseases | 1 | 2014 | 1084 | 0.250 |
Why?
|
Severity of Illness Index | 12 | 2023 | 15939 | 0.250 |
Why?
|
Ambulatory Care | 2 | 2015 | 2784 | 0.240 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3811 | 0.240 |
Why?
|
Prospective Studies | 19 | 2023 | 54921 | 0.230 |
Why?
|
Quality Indicators, Health Care | 1 | 2014 | 1813 | 0.230 |
Why?
|
Prognosis | 15 | 2023 | 30020 | 0.230 |
Why?
|
Digestive System Surgical Procedures | 1 | 2009 | 584 | 0.230 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2024 | 94 | 0.230 |
Why?
|
Plant Extracts | 1 | 2007 | 497 | 0.220 |
Why?
|
Endoscopy | 4 | 2020 | 1856 | 0.220 |
Why?
|
Infusions, Intravenous | 4 | 2014 | 2226 | 0.220 |
Why?
|
Randomized Controlled Trials as Topic | 10 | 2022 | 10377 | 0.220 |
Why?
|
Mucous Membrane | 3 | 2023 | 659 | 0.210 |
Why?
|
Colonic Pouches | 3 | 2016 | 122 | 0.210 |
Why?
|
Biological Therapy | 1 | 2024 | 140 | 0.210 |
Why?
|
Hypersensitivity, Immediate | 1 | 2005 | 349 | 0.200 |
Why?
|
Delphi Technique | 3 | 2021 | 888 | 0.200 |
Why?
|
Ileitis | 1 | 2022 | 39 | 0.200 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2257 | 0.200 |
Why?
|
Antibodies | 3 | 2023 | 2425 | 0.200 |
Why?
|
Physicians | 2 | 2017 | 4614 | 0.190 |
Why?
|
Cohort Studies | 12 | 2020 | 41791 | 0.190 |
Why?
|
Odds Ratio | 5 | 2020 | 9681 | 0.190 |
Why?
|
Time Factors | 10 | 2024 | 40267 | 0.190 |
Why?
|
Consensus | 4 | 2021 | 3212 | 0.190 |
Why?
|
Patient Readmission | 1 | 2015 | 3312 | 0.180 |
Why?
|
Probiotics | 3 | 2016 | 383 | 0.180 |
Why?
|
Predictive Value of Tests | 6 | 2018 | 15455 | 0.180 |
Why?
|
Hospitalization | 4 | 2018 | 10844 | 0.180 |
Why?
|
Pregnancy Complications | 2 | 2013 | 2971 | 0.180 |
Why?
|
Wound Healing | 4 | 2024 | 2812 | 0.180 |
Why?
|
Adolescent | 14 | 2023 | 89182 | 0.180 |
Why?
|
Venous Thromboembolism | 1 | 2014 | 1881 | 0.180 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2022 | 706 | 0.180 |
Why?
|
Research Design | 2 | 2015 | 6209 | 0.180 |
Why?
|
RNA, Antisense | 1 | 2020 | 135 | 0.180 |
Why?
|
Societies, Medical | 5 | 2021 | 3960 | 0.170 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2020 | 359 | 0.170 |
Why?
|
Early Detection of Cancer | 3 | 2020 | 3236 | 0.170 |
Why?
|
Disclosure | 3 | 2015 | 754 | 0.170 |
Why?
|
Intestinal Mucosa | 5 | 2021 | 3048 | 0.160 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2019 | 293 | 0.160 |
Why?
|
Interleukins | 1 | 2024 | 795 | 0.160 |
Why?
|
Health Services Research | 2 | 2017 | 1817 | 0.160 |
Why?
|
Follow-Up Studies | 16 | 2018 | 39405 | 0.160 |
Why?
|
Nitroimidazoles | 2 | 2010 | 118 | 0.160 |
Why?
|
Tuberculosis | 1 | 2011 | 2029 | 0.150 |
Why?
|
Diagnosis, Differential | 6 | 2013 | 13019 | 0.150 |
Why?
|
Vaccination | 1 | 2011 | 3431 | 0.150 |
Why?
|
Anticoagulants | 1 | 2014 | 4842 | 0.150 |
Why?
|
Sentinel Surveillance | 1 | 2020 | 292 | 0.150 |
Why?
|
Intra-Abdominal Fat | 1 | 2023 | 624 | 0.150 |
Why?
|
Recurrence | 6 | 2020 | 8501 | 0.150 |
Why?
|
Sexually Transmitted Diseases | 1 | 2024 | 666 | 0.150 |
Why?
|
Aged, 80 and over | 11 | 2022 | 59683 | 0.140 |
Why?
|
Risk Factors | 15 | 2019 | 74954 | 0.140 |
Why?
|
Drug Therapy, Combination | 4 | 2018 | 6319 | 0.140 |
Why?
|
Sensitivity and Specificity | 6 | 2021 | 14736 | 0.140 |
Why?
|
Moxibustion | 1 | 2016 | 8 | 0.140 |
Why?
|
Risk Assessment | 7 | 2019 | 24316 | 0.140 |
Why?
|
Anti-Bacterial Agents | 3 | 2022 | 7458 | 0.140 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1727 | 0.140 |
Why?
|
Trichuris | 1 | 2016 | 32 | 0.140 |
Why?
|
Cytokine Receptor Common beta Subunit | 1 | 2016 | 22 | 0.130 |
Why?
|
Focus Groups | 4 | 2021 | 1453 | 0.130 |
Why?
|
Hypnosis | 1 | 2016 | 84 | 0.130 |
Why?
|
Enteric Nervous System | 2 | 2017 | 213 | 0.130 |
Why?
|
Academic Medical Centers | 2 | 2017 | 2783 | 0.130 |
Why?
|
Plant Preparations | 1 | 2016 | 94 | 0.130 |
Why?
|
Chi-Square Distribution | 2 | 2014 | 3438 | 0.130 |
Why?
|
Radiography | 3 | 2017 | 6993 | 0.130 |
Why?
|
Herpes Zoster Vaccine | 1 | 2016 | 49 | 0.130 |
Why?
|
Neurofibromatosis 1 | 1 | 2001 | 561 | 0.130 |
Why?
|
Proctocolectomy, Restorative | 3 | 2016 | 191 | 0.130 |
Why?
|
Relaxation Therapy | 1 | 2016 | 181 | 0.120 |
Why?
|
Live Birth | 2 | 2016 | 516 | 0.120 |
Why?
|
Anastomosis, Surgical | 2 | 2016 | 989 | 0.120 |
Why?
|
Immunoglobulin Fab Fragments | 3 | 2011 | 446 | 0.120 |
Why?
|
Education, Medical, Continuing | 1 | 2020 | 828 | 0.120 |
Why?
|
Diagnosis-Related Groups | 1 | 2016 | 448 | 0.120 |
Why?
|
Aged | 17 | 2022 | 171544 | 0.120 |
Why?
|
Ileostomy | 1 | 2015 | 122 | 0.120 |
Why?
|
Integrins | 1 | 2019 | 843 | 0.120 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 790 | 0.120 |
Why?
|
Pregnancy | 6 | 2017 | 30198 | 0.120 |
Why?
|
Jews | 1 | 2016 | 358 | 0.120 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2014 | 85 | 0.120 |
Why?
|
Government Regulation | 1 | 2019 | 525 | 0.120 |
Why?
|
Frameshift Mutation | 1 | 2016 | 393 | 0.120 |
Why?
|
Needs Assessment | 1 | 2020 | 1142 | 0.110 |
Why?
|
Logistic Models | 3 | 2015 | 13323 | 0.110 |
Why?
|
Boston | 3 | 2016 | 9371 | 0.110 |
Why?
|
Infection Control | 1 | 2021 | 985 | 0.110 |
Why?
|
Ileum | 1 | 2016 | 558 | 0.110 |
Why?
|
Follicle Stimulating Hormone | 1 | 2016 | 726 | 0.110 |
Why?
|
Integrin alpha4 | 1 | 2013 | 88 | 0.110 |
Why?
|
Patient Compliance | 2 | 2014 | 2693 | 0.110 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 26373 | 0.110 |
Why?
|
Lymphoma | 2 | 2021 | 1907 | 0.110 |
Why?
|
Mind-Body Therapies | 1 | 2016 | 291 | 0.110 |
Why?
|
Public Health Practice | 1 | 2015 | 221 | 0.110 |
Why?
|
Adenosine Triphosphatases | 1 | 2017 | 842 | 0.110 |
Why?
|
ROC Curve | 2 | 2018 | 3622 | 0.110 |
Why?
|
Ganciclovir | 1 | 2013 | 256 | 0.100 |
Why?
|
Immunoglobulin G | 2 | 2016 | 4570 | 0.100 |
Why?
|
Salicylic Acid | 1 | 2013 | 62 | 0.100 |
Why?
|
Secondary Prevention | 4 | 2013 | 1476 | 0.100 |
Why?
|
Yoga | 1 | 2016 | 280 | 0.100 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 892 | 0.100 |
Why?
|
Injections, Subcutaneous | 2 | 2024 | 687 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4859 | 0.100 |
Why?
|
Self Report | 5 | 2015 | 3766 | 0.100 |
Why?
|
Child | 8 | 2023 | 80894 | 0.100 |
Why?
|
Leukocytes, Mononuclear | 3 | 2016 | 1855 | 0.100 |
Why?
|
Pyrroles | 1 | 2018 | 1126 | 0.100 |
Why?
|
Acupuncture Therapy | 1 | 2016 | 486 | 0.100 |
Why?
|
Autoantibodies | 1 | 2021 | 2126 | 0.100 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2014 | 344 | 0.100 |
Why?
|
Histocytochemistry | 1 | 2013 | 699 | 0.100 |
Why?
|
Chronic Disease | 3 | 2021 | 9380 | 0.100 |
Why?
|
Double-Balloon Enteroscopy | 1 | 2011 | 7 | 0.100 |
Why?
|
Lectins | 1 | 2013 | 490 | 0.100 |
Why?
|
Polyradiculopathy | 1 | 2011 | 23 | 0.100 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12092 | 0.090 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 419 | 0.090 |
Why?
|
Hematocrit | 1 | 2013 | 625 | 0.090 |
Why?
|
5'-Nucleotidase | 1 | 2012 | 164 | 0.090 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2012 | 355 | 0.090 |
Why?
|
Osteoarthritis, Hip | 1 | 2015 | 409 | 0.090 |
Why?
|
Placebos | 3 | 2024 | 1668 | 0.090 |
Why?
|
Meningitis, Viral | 1 | 2011 | 50 | 0.090 |
Why?
|
Polyethylene Glycols | 3 | 2011 | 1195 | 0.090 |
Why?
|
DNA, Viral | 1 | 2018 | 2205 | 0.090 |
Why?
|
Chickenpox Vaccine | 1 | 2011 | 40 | 0.090 |
Why?
|
Purines | 1 | 2014 | 615 | 0.090 |
Why?
|
Tuberculin Test | 1 | 2011 | 205 | 0.090 |
Why?
|
Abdominal Pain | 1 | 2017 | 1070 | 0.090 |
Why?
|
Models, Organizational | 1 | 2014 | 548 | 0.090 |
Why?
|
Tissue Distribution | 1 | 2014 | 2298 | 0.090 |
Why?
|
Patient Admission | 1 | 2018 | 1367 | 0.090 |
Why?
|
Acyclovir | 1 | 2011 | 267 | 0.090 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2011 | 71 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2023 | 20224 | 0.090 |
Why?
|
Hematologic Diseases | 1 | 2014 | 499 | 0.090 |
Why?
|
Steroids | 1 | 2015 | 936 | 0.090 |
Why?
|
Inflammation | 5 | 2014 | 10863 | 0.090 |
Why?
|
Self Efficacy | 1 | 2014 | 643 | 0.090 |
Why?
|
Program Development | 1 | 2016 | 1298 | 0.090 |
Why?
|
Mycobacterium | 1 | 2011 | 252 | 0.090 |
Why?
|
Antiviral Agents | 2 | 2013 | 3064 | 0.080 |
Why?
|
Piperidines | 1 | 2018 | 1660 | 0.080 |
Why?
|
Exercise Therapy | 1 | 2016 | 941 | 0.080 |
Why?
|
Length of Stay | 2 | 2015 | 6516 | 0.080 |
Why?
|
Graft vs Host Disease | 1 | 2022 | 3043 | 0.080 |
Why?
|
Case-Control Studies | 6 | 2017 | 22292 | 0.070 |
Why?
|
Infant, Low Birth Weight | 1 | 2013 | 875 | 0.070 |
Why?
|
Enterobacteriaceae Infections | 1 | 2010 | 187 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6541 | 0.070 |
Why?
|
Hypothalamic Hormones | 1 | 2008 | 145 | 0.070 |
Why?
|
Pituitary Hormones | 1 | 2008 | 182 | 0.070 |
Why?
|
Polysaccharides | 1 | 2014 | 1024 | 0.070 |
Why?
|
Mice, Inbred NOD | 2 | 2022 | 1839 | 0.070 |
Why?
|
Plants, Medicinal | 1 | 2007 | 167 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2021 | 12457 | 0.070 |
Why?
|
Receptors, Corticotropin-Releasing Hormone | 1 | 2007 | 88 | 0.070 |
Why?
|
Acute Disease | 2 | 2009 | 7242 | 0.070 |
Why?
|
Heparin | 1 | 2014 | 1636 | 0.070 |
Why?
|
Immune Tolerance | 2 | 2014 | 2324 | 0.070 |
Why?
|
Qualitative Research | 2 | 2015 | 3131 | 0.070 |
Why?
|
Melanins | 1 | 2008 | 289 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2020 | 3111 | 0.070 |
Why?
|
Dietary Supplements | 2 | 2016 | 3443 | 0.070 |
Why?
|
Pyrimidines | 1 | 2018 | 3048 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2016 | 1447 | 0.060 |
Why?
|
Forecasting | 2 | 2022 | 2948 | 0.060 |
Why?
|
Immunologic Memory | 1 | 2012 | 1374 | 0.060 |
Why?
|
Phytotherapy | 1 | 2007 | 298 | 0.060 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2007 | 360 | 0.060 |
Why?
|
Postoperative Complications | 3 | 2015 | 15854 | 0.060 |
Why?
|
Abdomen | 1 | 2011 | 1136 | 0.060 |
Why?
|
Osteoarthritis, Knee | 1 | 2015 | 1252 | 0.060 |
Why?
|
Intestinal Absorption | 1 | 2006 | 400 | 0.060 |
Why?
|
Antibodies, Viral | 1 | 2016 | 3211 | 0.060 |
Why?
|
Comorbidity | 1 | 2019 | 10588 | 0.060 |
Why?
|
Premedication | 1 | 2005 | 246 | 0.060 |
Why?
|
Antibiotic Prophylaxis | 1 | 2010 | 640 | 0.060 |
Why?
|
Clinical Competence | 1 | 2020 | 4847 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2014 | 1389 | 0.060 |
Why?
|
Biopsy | 2 | 2013 | 6808 | 0.060 |
Why?
|
Lung Diseases | 1 | 2014 | 1925 | 0.060 |
Why?
|
Interleukin-8 | 3 | 2016 | 704 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2014 | 1664 | 0.050 |
Why?
|
Parkinson Disease | 1 | 2018 | 2893 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2862 | 0.050 |
Why?
|
Placebo Effect | 1 | 2007 | 518 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2014 | 4411 | 0.050 |
Why?
|
Drug Resistance | 1 | 2009 | 1595 | 0.050 |
Why?
|
Psoriasis | 1 | 2011 | 927 | 0.050 |
Why?
|
Registries | 1 | 2019 | 8378 | 0.050 |
Why?
|
Adaptation, Psychological | 1 | 2014 | 2661 | 0.050 |
Why?
|
Phosphoglycerate Kinase | 1 | 2022 | 66 | 0.050 |
Why?
|
Fructose-Bisphosphate Aldolase | 1 | 2022 | 43 | 0.050 |
Why?
|
Metronidazole | 1 | 2004 | 233 | 0.050 |
Why?
|
Data Collection | 1 | 2012 | 3324 | 0.050 |
Why?
|
Genetic Variation | 1 | 2018 | 6606 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 3 | 2017 | 36849 | 0.050 |
Why?
|
Ciprofloxacin | 1 | 2004 | 313 | 0.050 |
Why?
|
Age Factors | 2 | 2016 | 18472 | 0.050 |
Why?
|
Benzene | 1 | 2022 | 106 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12775 | 0.050 |
Why?
|
Heart Diseases | 1 | 2014 | 2819 | 0.050 |
Why?
|
Immunity, Mucosal | 1 | 2004 | 493 | 0.050 |
Why?
|
Video Recording | 1 | 2006 | 974 | 0.050 |
Why?
|
Pilot Projects | 1 | 2014 | 8730 | 0.050 |
Why?
|
Formularies as Topic | 1 | 2021 | 94 | 0.050 |
Why?
|
Chemoprevention | 1 | 2003 | 326 | 0.050 |
Why?
|
Budesonide | 1 | 2022 | 162 | 0.040 |
Why?
|
Antibody Formation | 1 | 2005 | 1393 | 0.040 |
Why?
|
Bilirubin | 1 | 2022 | 438 | 0.040 |
Why?
|
Premature Birth | 1 | 2013 | 1814 | 0.040 |
Why?
|
Carcinoma, Papillary | 1 | 2006 | 793 | 0.040 |
Why?
|
United States | 3 | 2019 | 73144 | 0.040 |
Why?
|
Vitamin D | 1 | 2014 | 3311 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11854 | 0.040 |
Why?
|
Pharmaceutical Services | 1 | 2021 | 143 | 0.040 |
Why?
|
Regression Analysis | 1 | 2009 | 6350 | 0.040 |
Why?
|
Social Support | 1 | 2009 | 2190 | 0.040 |
Why?
|
Ultrasonography | 1 | 2013 | 6001 | 0.040 |
Why?
|
Quality-Adjusted Life Years | 2 | 2020 | 1735 | 0.040 |
Why?
|
Area Under Curve | 2 | 2014 | 1642 | 0.040 |
Why?
|
Interleukin-17 | 2 | 2015 | 922 | 0.040 |
Why?
|
Immunoglobulin E | 1 | 2005 | 1507 | 0.040 |
Why?
|
Animals | 8 | 2022 | 169322 | 0.040 |
Why?
|
Biomedical Research | 1 | 2014 | 3464 | 0.040 |
Why?
|
Health Personnel | 1 | 2012 | 3381 | 0.040 |
Why?
|
Body Mass Index | 1 | 2016 | 13050 | 0.040 |
Why?
|
Anaphylaxis | 1 | 2005 | 758 | 0.040 |
Why?
|
Intestines | 3 | 2016 | 1911 | 0.040 |
Why?
|
Feces | 1 | 2024 | 1516 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 18047 | 0.040 |
Why?
|
Patient Selection | 1 | 2009 | 4265 | 0.040 |
Why?
|
Mice | 7 | 2022 | 82004 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2022 | 1184 | 0.030 |
Why?
|
Causality | 1 | 2023 | 1255 | 0.030 |
Why?
|
Reference Standards | 1 | 2020 | 1013 | 0.030 |
Why?
|
Anti-Infective Agents | 1 | 2004 | 985 | 0.030 |
Why?
|
Dextran Sulfate | 1 | 2017 | 258 | 0.030 |
Why?
|
Health Care Surveys | 2 | 2014 | 2437 | 0.030 |
Why?
|
Administration, Rectal | 1 | 2015 | 69 | 0.030 |
Why?
|
Prevalence | 1 | 2013 | 15868 | 0.030 |
Why?
|
Methotrexate | 1 | 2022 | 1722 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2020 | 3627 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 2021 | 1082 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1622 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2007 | 3692 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2018 | 812 | 0.030 |
Why?
|
Antibodies, Fungal | 1 | 2014 | 33 | 0.030 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2014 | 83 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2018 | 876 | 0.030 |
Why?
|
Porins | 1 | 2014 | 78 | 0.030 |
Why?
|
Biomedical Technology | 1 | 2016 | 210 | 0.030 |
Why?
|
Salicylates | 1 | 2014 | 128 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2016 | 353 | 0.030 |
Why?
|
Sexual Behavior | 1 | 2024 | 2200 | 0.030 |
Why?
|
Cytodiagnosis | 1 | 2017 | 452 | 0.030 |
Why?
|
Motivation | 2 | 2014 | 2029 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3345 | 0.030 |
Why?
|
Infant | 2 | 2018 | 36512 | 0.030 |
Why?
|
Administration, Oral | 3 | 2006 | 4043 | 0.030 |
Why?
|
Life Style | 2 | 2015 | 3930 | 0.030 |
Why?
|
Cost-Benefit Analysis | 2 | 2020 | 5538 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2014 | 5898 | 0.030 |
Why?
|
Cytoskeleton | 1 | 2018 | 1176 | 0.030 |
Why?
|
Child, Preschool | 2 | 2018 | 42654 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2013 | 26410 | 0.030 |
Why?
|
Colorimetry | 1 | 2013 | 151 | 0.030 |
Why?
|
Probability | 2 | 2009 | 2482 | 0.020 |
Why?
|
Thyroid Neoplasms | 1 | 2006 | 2360 | 0.020 |
Why?
|
Anemia, Sickle Cell | 1 | 2001 | 1065 | 0.020 |
Why?
|
Quality of Life | 2 | 2014 | 13499 | 0.020 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2014 | 294 | 0.020 |
Why?
|
Serologic Tests | 1 | 2014 | 383 | 0.020 |
Why?
|
Pregnancy Rate | 1 | 2014 | 655 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2007 | 8051 | 0.020 |
Why?
|
Specialization | 1 | 2016 | 781 | 0.020 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2014 | 403 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2012 | 473 | 0.020 |
Why?
|
Gene Frequency | 1 | 2018 | 3615 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 937 | 0.020 |
Why?
|
Bone and Bones | 1 | 2021 | 2588 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2016 | 997 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2014 | 875 | 0.020 |
Why?
|
Autophagy | 1 | 2018 | 1350 | 0.020 |
Why?
|
Decision Trees | 1 | 2011 | 509 | 0.020 |
Why?
|
Incidence | 2 | 2009 | 21544 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2021 | 3471 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1753 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2013 | 997 | 0.020 |
Why?
|
Safety | 1 | 2013 | 1159 | 0.020 |
Why?
|
Trinitrobenzenesulfonic Acid | 1 | 2008 | 65 | 0.020 |
Why?
|
Genetic Loci | 1 | 2018 | 2630 | 0.020 |
Why?
|
Drug Eruptions | 1 | 2011 | 336 | 0.020 |
Why?
|
Reference Values | 2 | 2006 | 4941 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 2014 | 1478 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16716 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2012 | 1866 | 0.020 |
Why?
|
Urocortins | 1 | 2007 | 19 | 0.020 |
Why?
|
Monocytes | 1 | 2016 | 2594 | 0.020 |
Why?
|
Alleles | 1 | 2018 | 6892 | 0.020 |
Why?
|
Anxiety | 1 | 2021 | 4675 | 0.020 |
Why?
|
Postoperative Period | 1 | 2011 | 1830 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7443 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2013 | 1197 | 0.020 |
Why?
|
Computer Simulation | 1 | 2020 | 6277 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2011 | 1260 | 0.020 |
Why?
|
Health Services Accessibility | 2 | 2014 | 5511 | 0.020 |
Why?
|
Enema | 1 | 2006 | 141 | 0.020 |
Why?
|
Enterotoxins | 1 | 2007 | 365 | 0.020 |
Why?
|
Attitude to Health | 1 | 2014 | 2025 | 0.020 |
Why?
|
Genome, Human | 1 | 2018 | 4450 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3794 | 0.010 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2012 | 1376 | 0.010 |
Why?
|
Sex Distribution | 1 | 2009 | 2281 | 0.010 |
Why?
|
Administration, Topical | 1 | 2006 | 703 | 0.010 |
Why?
|
Population Surveillance | 1 | 2014 | 2598 | 0.010 |
Why?
|
Communicable Diseases | 1 | 2012 | 873 | 0.010 |
Why?
|
Age Distribution | 1 | 2009 | 2877 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2014 | 2678 | 0.010 |
Why?
|
Macrophages | 1 | 2018 | 5796 | 0.010 |
Why?
|
Neuropeptides | 1 | 2008 | 950 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2008 | 2931 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 8072 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2007 | 1246 | 0.010 |
Why?
|
Signal Transduction | 2 | 2016 | 23629 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14481 | 0.010 |
Why?
|
Mice, SCID | 1 | 2007 | 2632 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10656 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8750 | 0.010 |
Why?
|
Bacterial Toxins | 1 | 2007 | 923 | 0.010 |
Why?
|
Europe | 1 | 2008 | 3439 | 0.010 |
Why?
|
Quality Improvement | 1 | 2016 | 3858 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 19019 | 0.010 |
Why?
|
Primary Health Care | 1 | 2016 | 4748 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22355 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2007 | 2394 | 0.010 |
Why?
|
NF-kappa B | 1 | 2007 | 2487 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10464 | 0.010 |
Why?
|
Health Care Costs | 1 | 2011 | 3267 | 0.010 |
Why?
|
Pedigree | 1 | 2006 | 4545 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9508 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2008 | 9563 | 0.010 |
Why?
|
Cell Line | 1 | 2007 | 15593 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2007 | 12801 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11914 | 0.000 |
Why?
|